Back to 
Citadel Advisors LLC
Citadel Advisors LLC
APH
Showing 0 of 16 quarters
Position history for Citadel Advisors LLC's holdings in AMPIO PHARMACEUTICALS INC
No. Citadel Advisors exited its APH (Ampio Pharmaceuticals) position in Q3 2022. Its Q2 2022 13F listed 662,947 shares worth $111,000. Citadel Advisors already held APH in its Q4 2018 13F, the earliest on record, and held it in 15 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.